New radiation combo aims to boost second stem cell transplants for blood cancer patients
NCT ID NCT02333162
First seen Mar 15, 2026 · Last updated Jun 12, 2026 · Updated 18 times
Summary
This early-stage study tests adding a precise type of bone marrow radiation (IMTMI) to standard chemotherapy before a second donor stem cell transplant. The goal is to find the safest radiation dose and see if it helps prevent the cancer from returning. The study involves 30 adults with blood cancers that have come back after previous treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ADULT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.